Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin

Biomaterials

Volumn 33, Issue 35, 2012, Pages 8917-8927

  Lee, Joo Myung ^a   Choe, WonSeok ^a   Kim, Baek Kyung ^a   Seo, Won Woo ^a   Lim, Woo Hyun ^a   Kang, Chan Koo ^b   Kyeong, San ^b   Eom, Khee Dong ^b   Cho, Hyun Ju ^a   Kim, Young Chan ^a   Hur, Jin ^a   Yang, Han Mo ^a   Cho, Hyun Jai ^a   Lee, Yoon Sik ^b   Kim, Hyo Soo ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Endothelial progenitor cell; Re endothelialization; Restenosis; Stent; VE cadherin

Indexed keywords

ENDOTHELIAL PROGENITOR CELLS; RE-ENDOTHELIALIZATION; RESTENOSIS; STENT; VE-CADHERIN;

ANTIBODIES; ENDOTHELIAL CELLS; GLYCOPROTEINS; HEART VALVE PROSTHESES;

STENTS;

ANTI HUMAN CD34 ANTIBODY; ANTI HUMAN VASCULAR ENDOTHELIAL CADHERIN ANTIBODY; ANTIBODY; CYCLINE; STAINLESS STEEL; UNCLASSIFIED DRUG;

ARTICLE; BARE METAL STENT; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; NEOINTIMA; PRIORITY JOURNAL;

ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD34; CADHERINS; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; ENDOTHELIAL CELLS; ENDOTHELIUM; HUMANS; LEUKOCYTES, MONONUCLEAR; NEOINTIMA; STEM CELLS; STENTS;

EID: 84867140323     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.066     Document Type: Article

References (36)

1. Cook S., Ladich E., Nakazawa G., Eshtehardi P., Neidhart M., Vogel R., et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009, 120:391-399.
2. Finn A.V., Kolodgie F.D., Harnek J., Guerrero L.J., Acampado E., Tefera K., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005, 112:270-278.
3. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K., D'Agostino R., Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007, 356:1020-1029.
4. Carter A.J., Aggarwal M., Kopia G.A., Tio F., Tsao P.S., Kolata R., et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004, 63:617-624.
5. Lim W.H., Seo W.W., Choe W., Kang C.K., Park J., Cho H.J., et al. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation. Arterioscler Thromb Vasc Biol 2011, 31:2798-2805.
6. Kong D., Melo L.G., Mangi A.A., Zhang L., Lopez-Ilasaca M., Perrella M.A., et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004, 109:1769-1775.
7. Werner N., Junk S., Laufs U., Link A., Walenta K., Bohm M., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003, 93:e17-e24.
8. Kipshidze N., Dangas G., Tsapenko M., Moses J., Leon M.B., Kutryk M., et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 2004, 44:733-739.
9. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353.
10. Larsen K., Cheng C., Tempel D., Parker S., Yazdani S., den Dekker W.K., et al. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. Eur Heart J 2012, 33:120-128.
11. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
12. Shimizu K., Sugiyama S., Aikawa M., Fukumoto Y., Rabkin E., Libby P., et al. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001, 7:738-741.
13. Simper D., Stalboerger P.G., Panetta C.J., Wang S., Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 2002, 106:1199-1204.
14. Bystron M., Cervinka P., Spacek R., Kvasnak M., Jakabcin J., Cervinkova M., et al. Randomized comparison of endothelial progenitor cells capture stent versus cobalt-chromium stent for treatment of ST-elevation myocardial infarction. Six-month clinical, angiographic, and IVUS follow-up. Catheter Cardiovasc Interv 2010, 76:627-631.
15. Beijk M.A., Klomp M., Verouden N.J., van Geloven N., Koch K.T., Henriques J.P., et al. Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J 2010, 31:1055-1064.
16. Beijk M.A., Klomp M., van Geloven N., Koch K.T., Henriques J.P., Baan J., et al. Two-year follow-up of the Genous endothelial progenitor cell capturing stent versus the Taxus Liberte stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheter Cardiovasc Interv 2011, 78:189-195.
17. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112:1618-1627.
18. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288-293.
19. Lampugnani M.G., Resnati M., Raiteri M., Pigott R., Pisacane A., Houen G., et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 1992, 118:1511-1522.
20. Kang C.K., Lee Y.S. The surface modification of stainless steel and the correlation between the surface properties and protein adsorption. J Mater Sci Mater Med 2007, 18:1389-1398.
21. Komatsu R., Ueda M., Naruko T., Kojima A., Becker A.E. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation 1998, 98:224-233.
22. Aoki J., Serruys P.W., van Beusekom H., Ong A.T., McFadden E.P., Sianos G., et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) registry. J Am Coll Cardiol 2005, 45:1574-1579.
23. Co M., Tay E., Lee C.H., Poh K.K., Low A., Lim J., et al. Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. Am Heart J 2008, 155:128-132.
24. Miglionico M., Patti G., D'Ambrosio A., Di Sciascio G. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Catheter Cardiovasc Interv 2008, 71:600-604.
25. van Beusekom H.M., Ertas G., Sorop O., Serruys P.W., van der Giessen W.J. The Genous endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv 2012, 79:231-242.
26. Harraz M., Jiao C., Hanlon H.D., Hartley R.S., Schatteman G.C. CD34- blood-derived human endothelial cell progenitors. Stem Cells 2001, 19:304-312.
27. Fujiyama S., Amano K., Uehira K., Yoshida M., Nishiwaki Y., Nozawa Y., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003, 93:980-989.
28. Lewandowska K., Kaplan D., Husel W. CD34 expression on platelets. Platelets 2003, 14:83-87.
29. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008, 28:223-232.
30. Cho H.J., Kim T.Y., Park K.W., Zhang S.Y., Kim J.H., Kim S.H., et al. The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents. J Am Coll Cardiol 2006, 48:366-374.
31. Daniel J.M., Bielenberg W., Stieger P., Weinert S., Tillmanns H., Sedding D.G. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol 2010, 30:1890-1896.
32. Daniel J.M., Sedding D.G. Circulating smooth muscle progenitor cells in arterial remodeling. J Mol Cell Cardiol 2011, 50:273-279.
33. Saiura A., Sata M., Hirata Y., Nagai R., Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001, 7:382-383.
34. Zernecke A., Schober A., Bot I., von Hundelshausen P., Liehn E.A., Mopps B., et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005, 96:784-791.
35. Granada J.F., Inami S., Aboodi M.S., Tellez A., Milewski K., Wallace-Bradley D., et al. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv 2010, 3:257-266.
36. Li Q.L., Huang N., Chen C., Chen J.L., Xiong K.Q., Chen J.Y., et al. Oriented immobilization of anti-CD34 antibody on titanium surface for self-endothelialization induction. J Biomed Mater Res A 2010, 94:1283-1293.